Status
Conditions
Treatments
About
Tricuspid regurgitation (TR) is the second most common VHD after MR. Its prevalence also increases with age, with an estimated incidence of up to 6% in elderly population. When adjusted to age (among other confounders), survival is worse for patients with moderate and severe TR. We aim to explore the prevalence, mechanisms, and clinical implications of tricuspid valve regurgitation in elderly subjects screened at a tertiary center in Cairo, Egypt.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
700 participants in 1 patient group
Loading...
Central trial contact
Mohammad Abdelghani, MD, PhD; Mahmoud Abdelshafy, MBBCh, MSc
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal